Pancreatic Cancer Research

ResearcherNational Institutes of HealthActive in the last 2 years

Yaroslav Teper

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-9537-8804; OpenAlex author ID A5083662386. Sources: OpenAlex.

Their work

Papers
8 (first author 3, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
21
Papers, trials and grants by year

2014: 1 paper · 2015: none · 2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: 1 paper · 2021: 2 papers · 2022: 1 paper · 2023: 1 paper · 2024: none · 2025: 1 paper

Papers 8

  1. Stress and Obesity Signaling Converge on CREB Phosphorylation to Promote Pancreatic Cancer. First author DOI 10.1158/1541-7786.mcr-24-0785↗
  2. Low dosage combination treatment with metformin and simvastatin inhibits obesity-promoted pancreatic cancer development in male KrasG12D mice. Co-author DOI 10.1038/s41598-023-43498-9↗
  3. Opposite Effects of Src Family Kinases on YAP and ERK Activation in Pancreatic Cancer Cells: Implications for Targeted Therapy. Co-author DOI 10.1158/1535-7163.mct-21-0964↗
  4. Direct Effects of Lipopolysaccharide on Human Pancreatic Cancer Cells. First author DOI 10.1097/mpa.0000000000001790↗
  5. T Cell-Mediated Antitumor Immunity Cooperatively Induced By TGFβR1 Antagonism and Gemcitabine Counteracts Reformation of the Stromal Barrier in Pancreatic Canc… Co-author DOI 10.1158/1535-7163.mct-20-0620↗
  6. Pancreatic Macrophages: Critical Players in Obesity-Promoted Pancreatic Cancer. Co-author DOI 10.3390/cancers12071946↗
  7. Whole Genome Sequencing of Newly Established Pancreatic Cancer Lines Identifies Novel Somatic Mutation (c.2587G>A) in Axon Guidance Receptor Plexin A1 as Enhan… First author DOI 10.1371/journal.pone.0149833↗
  8. A novel chimeric antigen receptor against prostate stem cell antigen mediates tumor destruction in a humanized mouse model of pancreatic cancer. Co-author DOI 10.1089/hum.2013.209↗

Closest collaborators

The 21 strongest of 21 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Guido Eibl · 5 shared papers, 2020–2025 · strength 1.02
  2. James W. Sinnett‐Smith · 3 shared papers, 2022–2025 · strength 0.63
  3. Enrique Rozengurt · 3 shared papers, 2022–2025 · strength 0.63
  4. Oscar Joe Hines · 3 shared papers, 2021–2025 · strength 0.59
  5. Xiaoying Sun · 2 shared papers, 2023–2025 · strength 0.45
  6. Linda Ye · 2 shared papers, 2021–2023 · strength 0.33
  7. Udo Rudloff · 3 shared papers, 2014–2021 · strength 0.19
  8. Aurelia Lugea · 1 shared paper, 2023 · strength 0.18
  9. Richard T. Waldron · 1 shared paper, 2023 · strength 0.18
  10. Stephen Jacob Pandol · 1 shared paper, 2023 · strength 0.18
  11. Rebecca A. Sorber · 2 shared papers, 2016–2021 · strength 0.15
  12. Soichiro Ako · 1 shared paper, 2021 · strength 0.15
  13. Roxanne L. Massoumi · 1 shared paper, 2021 · strength 0.15
  14. Dandan Li · 1 shared paper, 2021 · strength 0.10
  15. Tashinga E. Bapiro · 1 shared paper, 2021 · strength 0.10
  16. Frances M. Richards · 1 shared paper, 2021 · strength 0.10
  17. Duncan Ian Jodrell · 1 shared paper, 2021 · strength 0.10
  18. Daniel Abate‐Daga · 1 shared paper, 2014 · strength 0.04
  19. William R. Burns · 1 shared paper, 2014 · strength 0.04
  20. Richard A. Morgan · 1 shared paper, 2014 · strength 0.04
  21. Eric Tran · 1 shared paper, 2014 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.